Cargando…

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Huang, Yuhsin Vivian, Waliany, Sarah, Lee, Daniel, Galdos, Francisco X., Witteles, Ronald M., Neal, Joel W., Fan, Alice C., Maecker, Holden T., Nguyen, Patricia K., Wu, Sean M., Zhu, Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Primers in Cardio-Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830194/ https://www.ncbi.nlm.nih.gov/pubmed/36636436 http://dx.doi.org/10.1016/j.jaccao.2022.08.012

Ejemplares similares

Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis
por: Witteles, Ronald M.
Publicado: (2021)

Racial and Ethnic Disparities in Cardio-Oncology: A Call to Action
por: Fazal, Muhammad, et al.
Publicado: (2021)

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?
por: Ghosh, Arjun K., et al.
Publicado: (2020)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
por: Peix, Amalia, et al.
Publicado: (2023)

Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020)

How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience
por: Jacob, Robin, et al.
Publicado: (2021)

Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy
por: Feng, Kent Y., et al.
Publicado: (2019)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

CARTing Away Cardiac Fibrosis
por: Epstein, Jonathan A.
Publicado: (2020)

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?
por: Kamphuis, Janine A.M., et al.
Publicado: (2019)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
por: Rubinstein, Samuel M., et al.
Publicado: (2021)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
por: Thuny, Franck, et al.
Publicado: (2022)

How to Treat Diffuse Large B-Cell Lymphoma: Oncologic and Cardiovascular Considerations
por: Kambhampati, Swetha, et al.
Publicado: (2023)

Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience
por: Minga, Iva, et al.
Publicado: (2023)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls
por: Tromp, Jasper, et al.
Publicado: (2020)

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020)

Palpitations in the Cancer Patient
por: Essa, Hani, et al.
Publicado: (2021)

Chest Pain in the Cancer Patient
por: Tyebally, Sara, et al.
Publicado: (2022)

Dyspnoea in Oncological Patients: A Brain Teaser
por: Keramida, Kalliopi, et al.
Publicado: (2023)

The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
por: Gent, David G, et al.
Publicado: (2023)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)

Advanced Imaging Modalities to Monitor for Cardiotoxicity
por: Seraphim, Andreas, et al.
Publicado: (2019)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
por: Tan, Li-Ling, et al.
Publicado: (2018)

Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients
por: Schiffer, Walter, et al.
Publicado: (2023)

Correction to: Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
por: Zhu, Han, et al.
Publicado: (2020)

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
por: Zhu, Han, et al.
Publicado: (2020)

Herd Immunity: Understanding COVID-19
por: Randolph, Haley E., et al.
Publicado: (2020)

T Cell Memory: Understanding COVID-19
por: Jarjour, Nicholas N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lrnuj3k4vtotgmtgvjj997icd2